Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (3)

Latest Articles

About This Stock More About This Stock
EC Holiday Fever Takes Hold Of Stock Investors, But A Pullback Is Needed
Article By: Sabrient Systems
Monday, November 24, 2014 3:15 PM EDT
Nothing goes up in a straight line, not even during the holidays, so a near-term market pullback would be a healthy way to prevent a steeper correction in January.
In this article: AGN, TXN, UPS, XTN, SOXX, AMGN, CELG, INTC, LSTR, BBH, SPY, VIX, ACT
Read
Profit By Connecting The Dots On The Next M&A Buyout
Article By: InvestorsAlley
Monday, November 24, 2014 10:00 AM EDT
We could be on the verge of another major oil M&A boom like the historic one that brought Exxon and Mobil together. Mergers and acquisitions have the potential to shake up a market and send some stocks soaring, but the best industry plays aren’t all that obvious.
In this article: AGN, BHI, BP, CLR, COP, CVX, GS, HAL, HP, NBR, NOV, OAS, PXD, SLB, WFT, PTEN, ACT, RDS-A
Read
Actavis Strikes $66 Billion Deal For Botox Maker Allergan
Article By: Zacks Investment Research
Tuesday, November 18, 2014 5:01 PM EDT
With the Allergan acquisition, Actavis will be able to strengthen its global presence especially in Canada, Europe and Southeast Asia and other high-value growth markets like China, India, the Middle East and Latin America.
In this article: AGN, VRX, BIIB, ACT
Read
Hot Bargains In Big Biotech
Article By: Bret Jensen
Tuesday, November 18, 2014 12:00 PM EDT
It has been an eventful year in the big pharma and biotech space, and a lot is happening in this space that biotech investors should take note of.
In this article: AGN, AVNR, REGN, AMGN, BIIB, CELG, GILD, ABBV
Read
E Large Cap Best And Worst Report
Article By: E.B. Capital Markets
Tuesday, November 18, 2014 8:57 AM EDT
The average large cap score is 68.31, above the four week moving average score of 67.91. The average large cap stock is trading -10.27% below its 52 week high, 2.75% above its 200 dma, has 3.57 days to cover held short, and is expected to see EPS growth of 10.77% next year.
In this article: AGN, ALU, APC, BK, CSX, MTD, RCL, VRX, WEC, SBSA
Read
Invest Like Kim Kardashian
Article By: Zacks Investment Research
Monday, November 17, 2014 5:36 PM EDT
In the news today due to a merger with Actavis that values Allergan at $66 billion, Allergan is a Zacks Rank #2 (Buy).
In this article: AGN, SKX, ZLTQ, ACT
Read

Latest Tweets for $AGN

No tweets yet!